查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1750819

美國腹部疝氣網片市場規模、佔有率、趨勢分析報告（按網片類型、適應症、手術、最終用途、細分市場預測，2025-2030 年）

U.S. Ventral Hernia Mesh Devices Market Size, Share & Trends Analysis Report By Mesh Type (Resorbable, Partially Absorbable), By Indication (Umbilical Hernia, Epigastric Hernia), By Procedure, By End Use, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 140 Pages | 商品交期: 2-10個工作天內

價格

市場規模與趨勢：

預計 2024 年美國腹壁疝氣網片市場價值將達到 3.567 億美元，預計 2025 年至 2030 年的複合年成長率為 8.27%。

疝氣病例的增加、網片修復技術的進步、向預防性醫療保健的轉變、對微創手術的偏好日益成長以及醫療保健基礎設施的不斷成長都是影響市場成長的因素。根據美國FDA 的數據，美國每年進行超過一百萬例疝氣修補手術。

疝氣修補術是全球最常見的外科手術之一。男性疝氣發生率高於女性。根據《國際外科雜誌》報道，每年約有 30 萬例腹部疝氣修復術。其中，75% 為原發性腹疝氣（主要為上腹部和臍疝氣），25% 為切口疝氣。此外，在美國，近 10% 至 30% 接受中線開放性手術的患者常見於切口疝氣。疝氣修補術的年度費用估計約為 32 億美元。這對患者來說是一項重大的醫療保健挑戰，也是美國醫療保健系統的主要財務障礙。

腹部疝氣網片的優惠報銷方案鼓勵患者選擇手術。政府和行業相關人員為患者提供易於取得的詳細報銷代碼和比例。代碼依疝氣類型（原發性vs 復發性疝氣）和手術方式（開放性手術 vs 腹腔鏡手術）分類。

腹疝氣補片的技術進步顯著改善了患者的預後並減少了併發症。其中一項顯著的創新是輕質複合補片的開發。這些補片，例如Parietex複合補片，結合了可吸收和不可吸收材料，在提供強度的同時，降低了術後不適和慢性疼痛的風險。這些進步也包括Deep Blue Medical Advances, Inc.的先進補片技術等創新。 2024年，該公司推出了T-Line Mini，這是其T-Line補片的縮小版，用於臍疝氣和小缺損。此外，其T-Line補片的塗層和生物合成複合材料版本正在開發中。

目錄

第1章調查方法與範圍

第2章執行摘要

第3章美國腹部疝氣網片市場變數、趨勢與範圍

  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 美國腹部疝氣網片市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析

第4章美國腹部疝氣網片市場：按網片類型進行的估計和趨勢分析

  • 細分儀表板
  • 美國腹疝氣網片市場：網片類型波動分析
  • 美國腹部疝氣網片市場：按網片類型分類的展望
  • 2018年至2030年市場規模、預測及趨勢分析
  • 可吸收網片
  • 部分吸收網
  • 不可吸收網片

第5章美國腹部疝氣網片市場（按適應症）：估計與趨勢分析

  • 細分儀表板
  • 美國腹疝氣網片市場：適應症差異分析
  • 美國腹部疝氣網片市場（按適應症）：展望
  • 2018年至2030年市場規模、預測及趨勢分析
  • 臍疝氣
  • 上腹疝
  • 切口疝氣
  • 其他

第6章。美國腹部疝氣網片市場（按程序）：估計和趨勢分析

  • 細分儀表板
  • 美國腹部疝氣網片市場：依程序進行的變化分析
  • 美國腹部疝氣網片市場（依手術類型）展望
  • 2018年至2030年市場規模、預測及趨勢分析
  • 開放性手術
  • 腹腔鏡手術
  • 機器人手術
  • 其他

第7章美國腹部疝氣網片市場：按最終用途的估計和趨勢分析

  • 細分儀表板
  • 美國腹疝氣網片市場：依最終用途進行的變化分析
  • 美國腹疝氣網片市場：最終用途展望
  • 2018年至2030年市場規模、預測及趨勢分析
  • 住院設施
  • 門診設施

第8章 競爭態勢

  • 市場參與企業分類
  • 2024年企業市場分析
  • 主要企業簡介
    • Medtronic plc
    • Becton, Dickinson and Company
    • Ethicon Inc.（Johnson &Johnson MedTech）
    • Meril Life Sciences Pvt. Ltd.
    • Novus Scientific AB
    • B. Braun SE
    • TELA Bio, Inc.
    • BG Medical LLC
    • Integra LifeSciences Corporation
    • WL Gore &Associates, Inc.
    • Atrium Medical
Product Code: GVR-4-68040-575-6

Market Size & Trends:

The U.S. ventral hernia mesh devices market size was estimated at USD 356.7 million in 2024 and is projected to grow at a CAGR of 8.27% from 2025 to 2030. The increasing cases of hernias, technological advancements in mesh repair, a shift towards preventive healthcare, growing preference for minimally invasive procedures, and a growing healthcare infrastructure are the factors affecting market growth. According to the U.S. FDA, over a million hernia repair procedures are performed annually in the U.S.

Hernia repair is one of the most common surgical procedures worldwide. The incidence of hernia is higher in men than in women. According to the International Journal of Surgery, approximately 300,000 ventral hernia repairs are performed annually. Among these, 75% are primary ventral hernia repairs (mainly epigastric and umbilical) and 25% are incisional hernia repairs. Furthermore, incisional hernias are common in nearly 10-30% of patients in the U.S. who undergo midline laparotomies. The annual costs for hernia repairs are estimated at approximately USD 3.2 billion. This is viewed as a major healthcare challenge for patients and a significant financial hurdle for the U.S. healthcare system.

The presence of favorable reimbursement scenarios for hernia mesh devices is encouraging patients to opt for surgery. The government and industry players provide patients with easy access to detailed reimbursement codes and ratios. The codes are granulated into types of hernias (primary or recurrent) and surgery methods (open or laparoscopic).

Technological advancements in hernia mesh devices have significantly improved patient outcomes and reduced complications. One notable innovation is the development of lightweight and composite meshes. These meshes, such as Parietex Composite Mesh, combine absorbable and nonabsorbable materials, providing strength while reducing postoperative discomfort and the risk of chronic pain. These advancements include innovations like Deep Blue Medical Advances, Inc.'s advanced mesh technology. In 2024, the company launched a smaller version of the T-Line Mesh, known as the T-Line Mini, tailored for umbilical hernias and small defects. Moreover, the T-Line Hernia Mesh's coated and biosynthetic composite versions are developing.

U.S. Ventral Hernia Mesh Devices Market Report Segmentation

This report forecasts country-level revenue growth and analyzes the latest industry trends and opportunities in each sub-segment from 2018 to 2030. For this study, Grand View Research has segmented the U.S. ventral hernia mesh devices market report based on mesh type, indication, procedure, and end use:

  • Mesh Type Outlook (Revenue, USD Million, 2018 - 2030)
  • Resorbable Mesh
  • Partially Absorbable Mesh
  • Non-resorbable Mesh
  • Indication Outlook (Revenue, USD Million 2018 - 2030)
  • Umbilical Hernia
  • Epigastric Hernia
  • Incisional Hernia
  • Others
  • Procedure Outlook (Revenue, USD Million 2018 - 2030)
  • Open Surgery
  • Laparoscopic Surgery
  • Robotic Surgery
  • Others
  • End Use Outlook (Revenue, USD Million 2018 - 2030)
  • Inpatient Facilities
  • Outpatient Facilities

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Segment Definitions
    • 1.2.1. Mesh Type
    • 1.2.2. Indication
    • 1.2.3. Procedure
    • 1.2.4. End Use
    • 1.2.5. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in the U.S.
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Mesh Type outlook
    • 2.2.2. Indication outlook
    • 2.2.3. Procedure outlook
    • 2.2.4. End-use outlook
  • 2.3. Regional outlook
  • 2.4. Competitive Insights

Chapter 3. U.S. Ventral Hernia Mesh Devices Market Variables, Trends & Scope

  • 3.1. Market Dynamics
    • 3.1.1. Market Driver Analysis
      • 3.1.1.1. Global Shift Toward Preventive Healthcare
      • 3.1.1.2. Supportive Government Policies
      • 3.1.1.3. Increasing Incidence of Hernias
      • 3.1.1.4. Technological Advancements in Mesh Repair
      • 3.1.1.5. Growing Preference for Minimally Invasive Procedures
    • 3.1.2. Market Restraint Analysis
      • 3.1.2.1. Complications Related to Mesh Implants
      • 3.1.2.2. High Costs of Advanced Meshes
      • 3.1.2.3. Product Recalls
  • 3.2. U.S. Ventral Hernia Mesh Devices Market Analysis Tools
    • 3.2.1. Industry Analysis - Porter's
      • 3.2.1.1. Bargaining power of suppliers
      • 3.2.1.2. Bargaining power of buyers
      • 3.2.1.3. Threat of substitutes
      • 3.2.1.4. Threat of new entrants
      • 3.2.1.5. Competitive rivalry
    • 3.2.2. PESTEL Analysis
      • 3.2.2.1. Political landscape
      • 3.2.2.2. Economic landscape
      • 3.2.2.3. Social landscape
      • 3.2.2.4. Technological landscape
      • 3.2.2.5. Environmental Landscape
      • 3.2.2.6. Legal Landscape

Chapter 4. U.S. Ventral Hernia Mesh Devices Market: Mesh Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. U.S. Ventral Hernia Mesh Devices Market: Mesh Type Movement Analysis
  • 4.3. U.S. Ventral Hernia Mesh Devices Market by Mesh Type Outlook (USD Million)
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 4.5. Resorbable Mesh
    • 4.5.1. Resorbable Mesh Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Partially Absorbable Mesh
    • 4.6.1. Partially Absorbable Mesh Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.7. Non-resorbable Mesh
    • 4.7.1. Non-resorbable Mesh Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. U.S. Ventral Hernia Mesh Devices Market: Indication Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. U.S. Ventral Hernia Mesh Devices Market: Indication Movement Analysis
  • 5.3. U.S. Ventral Hernia Mesh Devices Market by Indication Outlook (USD Million)
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 5.5. Umbilical Hernia
    • 5.5.1. Umbilical Hernia Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Epigastric Hernia
    • 5.6.1. Epigastric Hernia Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7. Incisional Hernia
    • 5.7.1. Incisional Hernia Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.8. Others
    • 5.8.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. U.S. Ventral Hernia Mesh Devices Market: Procedure Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. U.S. Ventral Hernia Mesh Devices Market: Procedure Movement Analysis
  • 6.3. U.S. Ventral Hernia Mesh Devices Market by Procedure Outlook (USD Million)
  • 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 6.5. Open Surgery
    • 6.5.1. Open Surgery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Laparoscopic Surgery
    • 6.6.1. Laparoscopic Surgery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7. Robotic Surgery
    • 6.7.1. Robotic Surgery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.8. Others
    • 6.8.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. U.S. Ventral Hernia Mesh Devices Market: End-use Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. U.S. Ventral Hernia Mesh Devices Market: End-use Movement Analysis
  • 7.3. U.S. Ventral Hernia Mesh Devices Market by End-use Outlook (USD Million)
  • 7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 7.5. Inpatient Facilities
    • 7.5.1. Inpatient Facilities Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Outpatient Facilities
    • 7.6.1. Outpatient Facilities Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Market Participant Categorization
  • 8.2. Company Market Position Analysis, 2024
  • 8.3. Key Company Profiles
    • 8.3.1. Medtronic plc
      • 8.3.1.1. Company overview
      • 8.3.1.2. Financial performance
      • 8.3.1.3. Product benchmarking
      • 8.3.1.4. Strategic initiatives
    • 8.3.2. Becton, Dickinson and Company
      • 8.3.2.1. Company overview
      • 8.3.2.2. Financial performance
      • 8.3.2.3. Product benchmarking
      • 8.3.2.4. Strategic initiatives
    • 8.3.3. Ethicon Inc. (Johnson & Johnson MedTech)
      • 8.3.3.1. Company overview
      • 8.3.3.2. Financial performance
      • 8.3.3.3. Product benchmarking
      • 8.3.3.4. Strategic initiatives
    • 8.3.4. Meril Life Sciences Pvt. Ltd.
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Product benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. Novus Scientific AB
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Product benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. B. Braun SE
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Product benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. TELA Bio, Inc.
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Product benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. BG Medical LLC
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Product benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. Integra LifeSciences Corporation
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Product benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. W. L. Gore & Associates, Inc.
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Product benchmarking
      • 8.3.10.4. Strategic initiatives
    • 8.3.11. Atrium Medical
      • 8.3.11.1. Company overview
      • 8.3.11.2. Financial performance
      • 8.3.11.3. Product benchmarking
      • 8.3.11.4. Strategic initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 U.S. ventral hernia mesh devices market, by mesh type, 2018 - 2030 (USD Million)
  • Table 4 U.S. ventral hernia mesh devices market, by indication, 2018 - 2030 (USD Million)
  • Table 5 U.S. ventral hernia mesh devices market, by procedure, 2018 - 2030 (USD Million)
  • Table 6 U.S. ventral hernia mesh devices market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Information Procurement
  • Fig. 2 Primary Research Pattern
  • Fig. 3 Market Research Approaches
  • Fig. 4 Value Chain-Based Sizing & Forecasting
  • Fig. 5 Market Formulation & Validation
  • Fig. 6 US ventral hernia mesh devices market segmentation
  • Fig. 7 Market driver analysis (Current & future impact)
  • Fig. 8 Market restraint analysis (Current & future impact)
  • Fig. 9 Market opportunity analysis (Current & future impact)
  • Fig. 10 SWOT Analysis by Factor (Political & Legal, Economic, and Technological)
  • Fig. 11 Porter's Five Forces Analysis
  • Fig. 12 US Ventral hernia mesh devices market, mesh type outlook key takeaways (USD Million)
  • Fig. 13 US Ventral hernia mesh devices market: mesh type movement analysis, 2023 & 2030 (USD Million)
  • Fig. 14 Resorbable mesh market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 15 Partially absorbable mesh market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 16 Non-resorbable mesh market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 17 U.S. Ventral hernia mesh devices market, indication outlook key takeaways (USD Million)
  • Fig. 18 U.S. Ventral hernia mesh devices market: indication movement analysis, 2023 & 2030 (USD Million)
  • Fig. 19 Umbilical hernia market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 Epigastric hernia market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Incisional hernia market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Others market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 U.S. Ventral hernia mesh devices market, procedure outlook key takeaways (USD Million)
  • Fig. 24 U.S. Ventral hernia mesh devices market: procedure movement analysis, 2023 & 2030 (USD Million)
  • Fig. 25 Open surgery market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Laparoscopic surgery market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Robotic surgery market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Others market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 U.S. Ventral hernia mesh devices market, end use outlook key takeaways (USD Million)
  • Fig. 30 U.S. Ventral hernia mesh devices market: end use movement analysis, 2023 & 2030 (USD Million)
  • Fig. 31 Inpatient facilities market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Outpatient facilities market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 List of key emerging companies/technology disruptors/innovators